Loading...

Dyne Therapeutics, Inc.

DYN•NASDAQ
Healthcare
Biotechnology
$20.02
$-0.39(-1.91%)
U.S. Market opens in 3h 7m

Dyne Therapeutics, Inc. (DYN) Stock Overview

Explore Dyne Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3.3B
P/E Ratio-5.78
EPS (TTM)$-3.47
ROE-0.61%
Fundamental Analysis

AI Price Forecasts

1 Month$20.70
3 Months$31.12
1 Year Target$18.78

DYN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Dyne Therapeutics, Inc. (DYN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.70, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $18.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -5.78 and a market capitalization of 3.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.91%
5-Day Change
0.20%
1-Month Change
14.009%
3-Month Change
20.75%
6-Month Change
17.21%
Year-to-Date (YTD) Change
2.35%
1-Year Change
114.58%
3-Year Change
90.67%
5-Year Change
15.52%
All-Time (Max) Change
-16.23%

Contact Information

https://www.dyne-tx.com
781 786 8230
1560 Trapelo Road, Waltham, MA, 02451

Company Facts

192 Employees
IPO DateSep 17, 2020
CountryUS
Actively Trading

Frequently Asked Questions